Your browser doesn't support javascript.
loading
Biosimilar infliximab for Behçet's syndrome: a case series.
Dincses, Elif; Esatoglu, Sinem Nihal; Ozguler, Yesim; Uygunoglu, Ugur; Hamuryudan, Vedat; Seyahi, Emire; Melikoglu, Melike; Fresko, Izzet; Ucar, Didar; Ozyazgan, Yilmaz; Kutlubay, Zekayi; Mat, M Cem; Yurdakul, Sebahattin; Siva, Aksel; Hatemi, Gulen.
Afiliação
  • Dincses E; Division of Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, and Behçet's Disease Research Centre, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Esatoglu SN; Division of Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, and Behçet's Disease Research Centre, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Ozguler Y; Division of Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, and Behçet's Disease Research Centre, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Uygunoglu U; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, and Department of Neurology, Istanbul University-Cerrahpasa, School of Medicine, Istanbul, Turkey.
  • Hamuryudan V; Division of Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, and Behçet's Disease Research Centre, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Seyahi E; Division of Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, and Behçet's Disease Research Centre, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Melikoglu M; Division of Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, and Behçet's Disease Research Centre, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Fresko I; Division of Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, and Behçet's Disease Research Centre, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Ucar D; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, and Department of Ophthalmology, Istanbul University-Cerrahpasa, School of Medicine, Istanbul, Turkey.
  • Ozyazgan Y; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, and Department of Ophthalmology, Istanbul University-Cerrahpasa, School of Medicine, Istanbul, Turkey.
  • Kutlubay Z; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, and Department of Dermatology, Istanbul University-Cerrahpasa, School of Medicine, Istanbul, Turkey.
  • Mat MC; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, and Department of Dermatology, Istanbul University-Cerrahpasa, School of Medicine, Istanbul, Turkey.
  • Yurdakul S; Division of Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, and Behçet's Disease Research Centre, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Siva A; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, and Department of Neurology, Istanbul University-Cerrahpasa, School of Medicine, Istanbul, Turkey.
  • Hatemi G; Division of Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, and Behçet's Disease Research Centre, Istanbul University-Cerrahpasa, Istanbul, Turkey. gulenhatemi@yahoo.com.
Clin Exp Rheumatol ; 37 Suppl 121(6): 111-115, 2019.
Article em En | MEDLINE | ID: mdl-31856937
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Síndrome de Behçet / Medicamentos Biossimilares / Infliximab Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Turquia
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Síndrome de Behçet / Medicamentos Biossimilares / Infliximab Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Turquia